ArticleBMC infectious diseases2025
Quality assessment of clinical practice guidelines for sepsis and variations in recommendations.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTo provide a clinical reference, we assessed the quality of clinical practice guidelines (CPGs) for sepsis management in adults and compared their key recommendations.
methodsRelevant CPGs for adult sepsis management were identified through searches of electronic databases, guideline repositories, and professional societies from January 1, 2018, to March 1, 2025. The Appraisal of Guidelines Research and Evaluation (AGREE) II instrument and the Appraisal of Guidelines for Research and Evaluation-Recommendation Excellence (AGREE-REX) were used to evaluate the methodological quality of CPGs and the quality of recommendations. Key recommendations were comprehensively extracted and compared.
resultsA total of 11 CPGs were included. The median (interquartile range [IQR]) scores for AGREE II domain were: scope and purpose, 88.89% (77.78–94.44%); stakeholder involvement, 83.33% (50.00–88.89%); rigor of development, 58.33% (50.00–83.33%); clarity of presentation, 94.40% (88.89–94.44%); applicability, 45.83% (33.33–66.67%); and editorial independence, 66.67% (58.33–91.67%). The AGREE-REX assessment indicated clinical applicability at 70.83% (63.89–83.33%), implementability at 58.33% (47.92–64.58%), and values and preferences at 30.21% (25.00–39.58%). In total, 552 key recommendations were extracted. Among guidelines utilizing the GRADE system, the proportion of evidence categorized as low (Grade C; n = 97, 40.93%) and very low quality (Grade D; n = 66, 27.85%) was substantially higher than that of high (Grade A; n = 15, 6.33%) and moderate-quality (Grade B; n = 59, 24.89%) evidence. Furthermore, weak recommendations (n = 168, 70.89%) were markedly more prevalent than strong recommendations (n = 69, 29.11%). Although guidelines for sepsis diagnosis were generally consistent, evidence gaps in hemodynamic management and antibiotic use led to controversial recommendations.
conclusionTreatment strategies for sepsis vary across guidelines and remain inconsistent. The quality of CPGs for sepsis management requires improvement, particularly in applicability and values and preferences. Future CPG developers should adhere strictly to standardized methodologies and focus on enhancing the dissemination and implementation of guidelines. In this study, we lay the foundation for future guideline development, aiming to synthesize evidence-based insights for clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.